Bailard, Inc. Astrazeneca PLC Transaction History

Bailard, Inc.

$3.58 Billion
Q1 2024

A detailed history of Bailard, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Bailard, Inc. holds 125,813 shares of AZN stock, worth $9.7 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

125,813

Previous 127,071 0.99%

Holding current value

$9.7 Million

Previous $8.56 Million 0.41%

% of portfolio

0.24%

Previous 0.26%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$61.03 - $69.57 $76,775 - $87,519	-1,258 Reduced 0.99%	125,813 $8.52 Million
Q4 2023 Feb 02, 2024	SELL	$61.89 - $69.28 $118,457 - $132,601	-1,914 Reduced 1.48%	127,071 $8.56 Million
Q3 2023 Oct 24, 2023	BUY	$64.85 - $71.7 $230,412 - $254,750	3,553 Added 2.83%	128,985 $8.73 Million
Q2 2023 Jul 20, 2023	SELL	$69.91 - $75.81 $995,378 - $1.08 Million	-14,238 Reduced 10.19%	125,432 $8.98 Million
Q1 2023 May 08, 2023	BUY	$63.15 - $71.6 $6,441 - $7,303	102 Added 0.07%	139,670 $9.69 Million

Q4 2022 Feb 02, 2023	BUY	$54.21 - $70.44 $420,452 - $546,332	7,756 Added 5.88%	139,568 $9.46 Million
Q3 2022 Oct 18, 2022	BUY	$53.02 - $135.75 $483,648 - $1.24 Million	9,122 Added 7.43%	131,812 $7.23 Million
Q2 2022 Jul 27, 2022	SELL	$59.26 - $71.14 $379,856 - $456,007	-6,410 Reduced 4.97%	122,690 $8.11 Million
Q1 2022 Apr 25, 2022	SELL	$55.72 - $67.12 $45,746 - $55,105	-821 Reduced 0.63%	129,100 $8.57 Million
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $434,104 - $512,937	-8,036 Reduced 5.83%	129,921 $7.57 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $79,117 - $86,564	1,424 Added 1.04%	137,957 $8.29 Million
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $425,999 - $529,463	-8,798 Reduced 6.05%	136,533 $8.18 Million
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $5.24 Million - $6.05 Million	111,211 Added 325.94%	145,331 $7.23 Million
Q4 2020 Feb 03, 2021	SELL	$48.52 - $58.02 $406,112 - $485,627	-8,370 Reduced 19.7%	34,120 $1.71 Million
Q3 2020 Nov 10, 2020	BUY	$53.07 - $61.1 $56,572 - $65,132	1,066 Added 2.57%	42,490 $2.33 Million
Q2 2020 Aug 12, 2020	SELL	$43.1 - $55.31 $585,039 - $750,777	-13,574 Reduced 24.68%	41,424 $2.19 Million
Q1 2020 Apr 16, 2020	BUY	$37.79 - $51.33 $145,038 - $197,004	3,838 Added 7.5%	54,998 $2.46 Million
Q4 2019 Jan 31, 2020	SELL	$42.46 - $50.46 $216,546 - $257,346	-5,100 Reduced 9.07%	51,160 $2.55 Million
Q3 2019 Oct 18, 2019	BUY	$40.12 - $45.47 $601,800 - $682,050	15,000 Added 36.35%	56,260 $2.51 Million
Q2 2019 Jul 26, 2019	BUY	$37.28 - $41.68 $149,120 - $166,720	4,000 Added 10.74%	41,260 $1.7 Million
Q1 2019 Apr 24, 2019	BUY	$35.49 - $43.02 $1.32 Million - $1.6 Million	37,260 New	37,260 $1.51 Million

Others Institutions Holding AZN

# of Institutions

1,248

Shares Held

477M

Call Options Held

5.99M

Put Options Held

5.24M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $239B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.

Account